These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33946783)

  • 1. Optimization of Very Low-Dose Formulation of Vitamin D3 with Lyophilizate for Dry Powder Inhalation System by Simple Method Based on Time-of-Flight Theory.
    Miyamoto K; Yanagisawa M; Taga H; Yamaji H; Akita T; Yamashita C
    Pharmaceutics; 2021 Apr; 13(5):. PubMed ID: 33946783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple Method to Measure the Aerodynamic Size Distribution of Porous Particles Generated on Lyophilizate for Dry Powder Inhalation.
    Miyamoto K; Taga H; Akita T; Yamashita C
    Pharmaceutics; 2020 Oct; 12(10):. PubMed ID: 33076510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient optimization of high-dose formulation of novel lyophilizates for dry powder inhalation by the combination of response surface methodology and time-of-flight measurement.
    Ohori R; Kiuchi S; Sugiyama S; Miyamoto K; Akita T; Yamashita C
    Int J Pharm; 2020 May; 581():119255. PubMed ID: 32217154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiolabeling Method for Lyophilizate for Dry Powder Inhalation Formulations.
    Miyamoto K; Akita T; Yamashita C
    Pharmaceutics; 2022 Mar; 14(4):. PubMed ID: 35456593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dry granulation of vitamin D3 and iron in corn starch matrix: Powder flow and structural properties.
    Ahmed J; Thomas L; Mulla MZ; Al-Attar H; Maniruzzaman M
    Food Res Int; 2023 Mar; 165():112497. PubMed ID: 36869503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary administration of 1,25-dihydroxyvitamin D3 to the lungs induces alveolar regeneration in a mouse model of chronic obstructive pulmonary disease.
    Horiguchi M; Hirokawa M; Abe K; Kumagai H; Yamashita C
    J Control Release; 2016 Jul; 233():191-7. PubMed ID: 27164543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a dry powder inhaler, the Ultrahaler, containing triamcinolone acetonide using in vitro-in vivo relationships.
    Lim JG; Shah B; Rohatagi S; Bell A
    Am J Ther; 2006; 13(1):32-42. PubMed ID: 16428920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dry-Powder Inhaler Formulation of Rifampicin: An Improved Targeted Delivery System for Alveolar Tuberculosis.
    Rawal T; Kremer L; Halloum I; Butani S
    J Aerosol Med Pulm Drug Deliv; 2017 Dec; 30(6):388-398. PubMed ID: 28510480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dispersibility and Storage Stability Optimization of High Dose Isoniazid Dry Powder Inhalation Formulations with L-Leucine or Trileucine.
    Sibum I; Hagedoorn P; Kluitman MPG; Kloezen M; Frijlink HW; Grasmeijer F
    Pharmaceutics; 2019 Dec; 12(1):. PubMed ID: 31881695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Delivery of hGhrelin Derivative by Lyophilizate for Dry Powder Inhalation System in Monkeys.
    Miyamoto K; Ishibashi Y; Akita T; Yamashita C
    Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33562278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, optimization, and in vitro simulated inhalation delivery of carvedilol nanoparticles loaded on a coarse carrier intended for pulmonary administration.
    Abdelbary AA; Al-mahallawi AM; Abdelrahim ME; Ali AM
    Int J Nanomedicine; 2015; 10():6339-53. PubMed ID: 26491298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel dry powder inhalation system based on dispersion of lyophilisates.
    Claus S; Schoenbrodt T; Weiler C; Friess W
    Eur J Pharm Sci; 2011 May; 43(1-2):32-40. PubMed ID: 21440061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Air permeability of powder: a potential tool for Dry Powder Inhaler formulation development.
    Le VN; Robins E; Flament MP
    Eur J Pharm Biopharm; 2010 Nov; 76(3):464-9. PubMed ID: 20854906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of poly(lactic-co-glycolic acid) microparticles as a carrier for pulmonary delivery of recombinant human interleukin-2: II. In vitro studies on aerodynamic properties of dry powder inhaler formulations.
    Devrim B; Bozkır A; Canefe K
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1376-86. PubMed ID: 21548727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and evaluation of insulin dry powder for inhalation.
    Mahesh Kumar T; Misra A
    Drug Dev Ind Pharm; 2006 Jul; 32(6):677-86. PubMed ID: 16885123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo evaluation of a dry powder endotracheal insufflator device for use in dose-dependent preclinical studies in mice.
    Duret C; Wauthoz N; Merlos R; Goole J; Maris C; Roland I; Sebti T; Vanderbist F; Amighi K
    Eur J Pharm Biopharm; 2012 Aug; 81(3):627-34. PubMed ID: 22538097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation of novel dry powder inhalation for fluticasone propionate and salmeterol xinafoate with capsule-based device.
    Kim KS; Kim JH; Jin SG; Kim DW; Kim JO; Yong CS; Youn YS; Oh KT; Woo JS; Choi HG
    Pharm Dev Technol; 2018 Feb; 23(2):158-166. PubMed ID: 28612675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigations on the Mechanism of Magnesium Stearate to Modify Aerosol Performance in Dry Powder Inhaled Formulations.
    Jetzer MW; Schneider M; Morrical BD; Imanidis G
    J Pharm Sci; 2018 Apr; 107(4):984-998. PubMed ID: 29247741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content.
    Shalash AO; Molokhia AM; Elsayed MM
    Eur J Pharm Biopharm; 2015 Oct; 96():291-303. PubMed ID: 26275831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride.
    Karimi K; Katona G; Csóka I; Ambrus R
    J Pharm Biomed Anal; 2018 Jan; 148():73-79. PubMed ID: 28965047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.